Epcoritamab combined with R-CHOP significantly improved progression free survival in patients with newly diagnosed DLBCL across both the primary endpoint and total populations.

Researchers evaluated the optimal duration of neoadjuvant radiotherapy for patients with locally advanced rectal cancer.

Urine cell-free (cf)RNA analysis could represent a promising biomarker for bladder cancer, according to a study published online Oct. 2 in Nature Medicine. Kevin J. Liu, PhD, from Stanford University ...

SM-AML can remain occult until cytoreduction shows MC proliferation, highlighting a potential role for SM evaluation in KIT-positive AML.

Supported by phase 3 OASIS-4 data, elinzanetant significantly reduced daily hot flash frequency in women receiving endocrine therapy for HR-positive breast cancer.

A systematic review and meta-analysis evaluated qualitative evidence on the experiences of MBC survivors to understand how they cope with associated challenges.

Cancer survivors are less likely to be physically active than adults without a cancer history, although physical activity (PA) increased in cancer survivors from 2018 to 2024, according to a study ...

A longitudinal study assessed cognitive trajectories in older and younger adults receiving CAR T-cell therapy for large B-cell lymphoma.

Quarterly nursing quality summits are evaluated as a strategy to enhance leadership accountability, drive zero harm, and ...

A chemotherapy-free, response-adapted regimen of frontline mosunetuzumab achieved high complete response rates and durable remission in patients with untreated FL or MZL.

In this study, researchers examined approval and fill rates of specialty prescriptions for blood cancers among Medicare and commercially insured patients.

A cross-sectional study evaluated oncology nurses' readiness, knowledge, and confidence in incorporating genomics into practice to identify educational needs for cancer care.